Study shows Sinovac gives kids 'mild or modest' protection vs COVID-19 variants | Inquirer

Study shows Sinovac gives kids ‘mild or modest’ protection vs COVID-19 variants

By: - Reporter /
/ 01:06 PM March 24, 2022

China's Sinovac

(REUTERS)

MANILA, Philippines — Sinovac’s vaccine, according to a recent study,  gives children “mild or modest” protection against COVID-19 variants, a pediatric infectious disease specialist said Thursday.

“So, merong (there is a) mild or modest protection against [Omicron and Delta] variants,” Dr. Ma. Liza Antoinette Gonzales said in a virtual forum.

Article continues after this advertisement

The study assessed the safety and immune response of both humoral and cellular immunity against virus variants in healthy children and adolescents in Chile.

FEATURED STORIES

The data was collected from 963 Chilean children aged three to 17 who were inoculated with Sinovac’s vaccine in a four-week interval.

The Food and Drug Administration earlier allowed the use of Sinovac’s COVID-19 vaccine for children aged six and above.

Article continues after this advertisement

“Ang ginamit nila pseudovirus neutralization assay, so laboratory pa lang. Hindi pa talaga natin alam how it will do in the real world. But, at least we know na meron both neutralizing antibodies as well as T-cell responses against these two variants,” Gonzales pointed out.

Article continues after this advertisement

(What they used is a pseudovirus neutralization assay, so it’s just a laboratory method. We do not know yet how it will do in the real world. But, at least we know that there are both neutralizing antibodies as well as T-cell responses against these two variants.)

Article continues after this advertisement

Gonzales said that further studies are needed to conclude that they are effective against COVID-19 variants.

 Sinovac formulation, dosage

Meanwhile, Dr. Nina Gloriani, Vaccine Expert Panel-Technical Working Group for COVID-19 Vaccines and Development chairperson, explainedwhy there is no difference in the formulation and dosage of Sinovac’s vaccine for adults and children.

Article continues after this advertisement

“Mas mataas ‘yung immune response doon sa higher dose that is why ‘yan ‘yung higher dose that is actually being given to the adults… Lower than that, wala kang protection,” she said.

(There is a higher immune response with the higher dose that is why the higher dose tis what’s given to adults, a lower dose will not offer any protection.)

Sinovac’s vaccine is administered in two doses, 0.5 milliliters each, 28 days apart.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

In comparison, Pfizer’s vaccine for children aged five to 11 is reformulated.

 gsg

For more news about the novel coronavirus click
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this

EDITORS' PICK
entertainment
business
business
business
usa
entertainment
TAGS: Children, COVID-19, minors, Sinovac, vaccine

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2024 | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.